argenx

Euronext Amsterdam · LEI 7245009C5FZE6G9ODQ71· Fiscal year 2025

Staff cost per employee
Not disclosed
Employees
Not disclosed

Reference: average annual pay in Healthcare & Pharma, Netherlands: $54.6K (Eurostat earn_ses22_26 (SES 2022), 2022 · full-time equivalent, firms with 10+ staff). Official government wage statistics for the whole industry, not this company's pay. Definitions differ by country; see the source.

Quick read

  • Revenue grew 89.9% year over year.
  • Revenue has grown two years in a row.
  • Operating margin was 25.4% in 2025.
  • Operating loss of $21.7M in 2024.

Last 3 years

Revenue
$1.2B2023$2.2B2024$4.2B2025
Operating income
-$425.0M2023-$21.7M2024$1.1B2025

See the share price on Google Finance ↗

Investor metrics

2025
Operating margin
25.4%
Net margin
31.1%
ROE
17.6%
Debt-to-equity
18.6%
Equity ratio
84.3%

Staff costs from the annual report (wages, social charges, pensions) divided by the average number of employees. Usually higher than take-home pay.

Source: ESEF annual report via filings.xbrl.org · View the annual report (filings.xbrl.org)

Not investment advice. Figures come from public filings and may contain errors.